Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-02-01

FDA Approved: SOMA — Supplemental Application (Viatris Specialty LLC)

View source ↗

Summary

FDA approved a supplemental application for Soma (carisoprodol) submitted by Viatris Specialty LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SOMA (carisoprodol)

Snippet

SUPPL AP for SOMA (CARISOPRODOL)